Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Amortization of Deferred Charges (2016 - 2024)

Skinvisible (SKVI) has disclosed Amortization of Deferred Charges for 14 consecutive years, with $12814.0 as the latest value for Q4 2024.

  • Quarterly Amortization of Deferred Charges changed 0.01% to $12814.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $50973.0 through Dec 2024, down 96.01% year-over-year, with the annual reading at $50973.0 for FY2024, 96.01% down from the prior year.
  • Amortization of Deferred Charges hit $12814.0 in Q4 2024 for Skinvisible, roughly flat from $12813.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $1.2 million in Q1 2023 to a low of $12673.0 in Q1 2024.
  • Historically, Amortization of Deferred Charges has averaged $165021.0 across 5 years, with a median of $165067.0 in 2020.
  • Biggest five-year swings in Amortization of Deferred Charges: surged 651.89% in 2023 and later crashed 98.98% in 2024.
  • Year by year, Amortization of Deferred Charges stood at $168624.0 in 2020, then decreased by 10.88% to $150276.0 in 2021, then increased by 9.98% to $165276.0 in 2022, then plummeted by 92.25% to $12813.0 in 2023, then grew by 0.01% to $12814.0 in 2024.
  • Business Quant data shows Amortization of Deferred Charges for SKVI at $12814.0 in Q4 2024, $12813.0 in Q3 2024, and $12673.0 in Q2 2024.